Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | PRKCA | P17252 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.30 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL28988905 | 0.98 | RECQL (0.55) | RECQLTSHRALDH1A1PRKCATDP1 | |
| SCHEMBL790709 | 0.98 | RECQL (0.58) | RECQLTSHRALDH1A1PRKCATDP1 | |
| SCHEMBL22528173 | 0.96 | RECQL (0.56) | RECQLTSHRALDH1A1PRKCATDP1 | |
| SCHEMBL9355862 | 0.96 | RECQL (0.56) | RECQLTSHRALDH1A1PRKCATDP1 | |
| SCHEMBL30579947 | 0.96 | RECQL (0.56) | RECQLTSHRALDH1A1PRKCATDP1 | |
| Ammonia Solution, Strong SCHEMBL28032182 | 0.96 | RECQL (0.56) | RECQLTSHRALDH1A1PRKCATDP1 | |
| Sulfuric Acid SCHEMBL28988908 | 0.91 | RECQL (0.52) | RECQLTSHRALDH1A1PRKCATDP1 | |
| SCHEMBL28910564 | 0.89 | RECQL (0.47) | RECQLTSHRALDH1A1 | |
| SCHEMBL28910565 | 0.89 | RECQL (0.47) | RECQLTSHRALDH1A1PRKCATDP1 | |
| SCHEMBL28209266 | 0.87 | RECQL (0.48) | RECQLTSHRALDH1A1PRKCATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026106948-A1 | FIRE RETARDANT COMPOSITIONS CONTAINING ONE OR MORE SURFACTANTS | PERIMETER SOLUTIONS LP (US) | 2026-05-21 | — | — | WO | claimed |
| EP-4061857-B1 | POLYMER DISPERSION MADE FROM (METH)ACRYLATES HAVING LONG SIDE CHAINS | EVONIK OPERATIONS GMBH (DE) | 2026-05-06 | — | — | EP | claimed |
| US-12605321-B2 | Personal care compositions | COLGATE-PALMOLIVE COMPANY (US) | 2026-04-21 | — | — | US | claimed |
| US-20250268832-A1 | Pretomanid Compositions | THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC. | 2025-08-28 | — | — | US | claimed |
| WO-2025123991-A1 | ARRAY-TYPE FLEXIBLE TACTILE SENSOR AND MANUFACTURING METHOD THEREFOR, AND TACTILE SENSING SYSTEM | 广东粤港澳大湾区国家纳米科技创新研究院 | 2025-06-19 | — | — | WO | claimed |
| CN-119775979-A | Stable foam control agent with rapid dispersion | 江苏四新科技应用研究所股份有限公司 | 2025-04-08 | — | — | CN | claimed |
| CN-119615411-A | Production process of circularly regenerated polylactic acid and low-temperature spandex fabric | 深圳市娜尔思时装有限公司 | 2025-03-14 | — | — | CN | claimed |
| US-20250064053-A1 | DISPERSANT SYSTEMS TO PREVENT CRYSTAL GROWTH IN SUSPENSION CONCENTRATE COMPOSITIONS | FMC CORP (US) | 2025-02-27 | — | — | US | claimed |
| CN-118930747-A | High-transparency, low-gloss and high-performance aqueous acrylate wood emulsion and preparation method thereof | 山西运研新材料有限公司 | 2024-11-12 | — | — | CN | claimed |
| EP-4447670-A1 | DISPERSANT SYSTEMS TO PREVENT CRYSTAL GROWTH IN SUSPENSION CONCENTRATE COMPOSITIONS | FMC Corporation (US) | 2024-10-23 | — | — | EP | claimed |
| US-5132207-A | Single stranded DNA reacting to form double stranded, detection of bacteria, precipitating agent | GEN-PROBE INCORPORATED (US) | 1992-07-21 | — | — | US | claimed |
| US-5080822-A | AQUEOUS DEGREASER COMPOSITIONS CONTAINING AN ORGANIC SOLVENT AND A SOLUBILIZING COUPLER | BUCKEYE INTERNATIONAL, INC. (US) | 1992-01-14 | — | — | US | claimed |
| WO-1991015565-A1 | IMPROVED AQUEOUS DEGREASER COMPOSITIONS | BUCKEYE INTERNATIONAL, INC. (US) | 1991-10-17 | — | — | WO | claimed |
| EP-0420097-A2 | Coreactable powdered compositions | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY, INC. (US) | 1991-04-03 | — | — | EP | claimed |
| EP-0288618-A1 | Method for releasing RNA and DNA from cells | GEN-PROBE INCORPORATED (US) | 1988-11-02 | — | — | EP | claimed |
| EP-0229442-A1 | Accelerated nucleic acid reassociation method | GEN-PROBE INCORPORATED (US) | 1987-07-22 | — | — | EP | claimed |
| EP-0075442-B1 | PROCESS FOR PRODUCING BENZOYL PEROXIDE CRYSTALS OF A SMALL SIZE | WARNER-LAMBERT COMPANY (US) | 1985-07-24 | — | — | EP | claimed |
| US-4401835-A | ADDING A SOLUTION OF BENZOYL PEROXIDE AND PRECIPITATION PROMOTER TO AN AQUEOUS SOLUTION OF A DISPERSANT | WARNER-LAMBERT COMPANY (US) | 1983-08-30 | — | — | US | claimed |
| EP-0075442-A1 | Process for producing benzoyl peroxide crystals of a small size | WARNER-LAMBERT COMPANY (US) | 1983-03-30 | — | — | EP | claimed |
| US-4309502-A | ANALYSIS FOR BOTH IN SINGLE CUVETTE | BECKMAN INSTRUMENTS, INC. (US) | 1982-01-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250268832-A1 | Pretomanid Compositions | HPSE, ALG3, ACMSD | RECQL 2061/4885TSHR 2083/4885ALDH1A1 3167/4885 |
| US-12605321-B2 | Personal care compositions | SMURF1, S100A10, SMURF2 | RECQL 3824/4885TSHR 3822/4885ALDH1A1 3142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.